Atlas Trials

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Clinical trial NCT03427359 · COMPLETED

Trial details

NCT number
NCT03427359
Sponsor
The University of Hong Kong-Shenzhen Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2015-01-22
Primary completion
2017-12-31
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.